India to develop 300 million doses of Russia’s vaccine candidate Sputnik V
India is working on production of about 300 million doses of the Russian Coronavirus vaccine candidate Sputnik V in 2021, according to the Head of the Russian Direct Investment Fund (RDIF), Kirill Dmitrev. As per the reports of one of the News Agency, Dmitrev said, “In India, we have agreements with four large manufacturers… India…